OverviewSuggest Edit

iRhythm Technologies is a digital healthcare company. It develops biosensing technology based on cloud-based data analytics and machine learning. The company offers Zio, a platform for early heart disease diagnostics.
TypePublic
Founded2006
HQSan Francisco, CA, US
Websiteirhythmtech.com
Employee Ratings3.6
Overall CultureC-

Latest Updates

Employees (est.) (Dec 2019)997(+34%)
Job Openings86
Revenue (FY, 2020)$265.2 M(+24%)
Share Price (Sept 2021)$61.3(-5%)
Cybersecurity ratingAMore

Key People/Management at iRhythm Technologies

Michael J. Coyle

Michael J. Coyle

President, Chief Executive Officer
Douglas Devine

Douglas Devine

Chief Financial Officer
Allan Wilsker

Allan Wilsker

EVP of Information Technology and Customer Service
Judy Lenane

Judy Lenane

Executive Vice President, Products and Chief Clinical Officer
Mark Day

Mark Day

EVP of Research & Development
Daniel G. Wilson

Daniel G. Wilson

Executive Vice President of Strategy, Corporate Development and Investor Relations
Show more

iRhythm Technologies Office Locations

iRhythm Technologies has offices in San Francisco, Cypress, Houston, Lincolnshire and in 1 other location
San Francisco, CA, US (HQ)
699 8th St # 600, San Francisco
Cypress, CA, US
11085 Knott Ave
Houston, TX, US
5775 North Sam Houston Parkway West, Suite 200
Lincolnshire, IL, US
2 Marriott Dr
London, GB
Seal House, 1 Swan Ln, Bridge
Show all (5)

iRhythm Technologies Financials and Metrics

iRhythm Technologies Revenue

Embed Graph
View revenue for all periods
iRhythm Technologies's revenue was reported to be $265.17 m in FY, 2020
USD

Revenue (FY, 2020)

265.2m

Gross profit (FY, 2020)

194.9m

Gross profit margin (FY, 2020), %

73.5%

Net income (FY, 2020)

(43.8m)

EBIT (FY, 2020)

(43.7m)

Market capitalization (14-Sept-2021)

1.8b

Closing stock price (14-Sept-2021)

61.3

Cash (31-Dec-2020)

88.6m

EV

1.8b
iRhythm Technologies's current market capitalization is $1.8 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

98.5m147.3m214.6m265.2m

Revenue growth, %

50%46%

Cost of goods sold

27.7m38.6m52.5m70.3m

Gross profit

70.8m108.7m162.1m194.9m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

30.6m35.5m38.1m47.2m53.3m54.7m63.5m50.9m71.9m

Cost of goods sold

8.6m9.5m9.9m11.7m12.8m13.8m16.1m15.5m18.2m

Gross profit

22.0m26.0m28.2m35.5m40.5m40.9m47.5m35.4m53.7m

Gross profit Margin, %

72%73%74%75%76%75%75%70%75%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

8.7m20.0m20.5m88.6m

Accounts Receivable

13.0m22.0m23.9m29.9m

Prepaid Expenses

2.6m4.1m4.3m7.4m

Inventories

1.7m2.1m4.0m5.3m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Cash

16.5m19.2m17.3m28.2m16.2m34.6m56.5m81.7m95.3m

Accounts Receivable

17.2m19.1m20.5m28.3m29.1m25.0m24.2m22.9m29.0m

Prepaid Expenses

1.8m2.5m2.8m3.8m3.7m3.7m4.2m3.7m4.7m

Inventories

1.9m2.2m2.3m2.5m2.8m3.5m4.2m5.0m5.1m
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(29.4m)(48.3m)(54.6m)(43.8m)

Depreciation and Amortization

1.6m2.3m3.4m6.9m

Inventories

(293.0k)(380.0k)(2.0m)(1.4m)

Accounts Payable

634.0k(192.0k)5.6m(3.9m)
USDFY, 2017

Revenue/Employee

171.3k

Debt/Equity

0.4 x

Debt/Assets

0.3 x

Financial Leverage

1.7 x
Show all financial metrics

iRhythm Technologies Revenue Breakdown

Embed Graph

iRhythm Technologies revenue breakdown by business segment: 47.5% from Contracted payors, 5.0% from Non-contracted payors, 27.5% from Centers for Medicare & Medicaid and 20.1% from Healthcare Institutions

iRhythm Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

iRhythm Technologies Online and Social Media Presence

Embed Graph

iRhythm Technologies Company Culture

  • Overall Culture

    C-

    65/100

  • CEO Rating

    F

    46/100

  • Compensation

    C

    67/100

Learn more on Comparably

iRhythm Technologies News and Updates

Should You Buy iRhythm Technologies Stock At $75?

We believe that the stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and cardiac monitoring products, looks undervalued at current levels of around $75. IRTC stock is actually at the same levels it was on March 23, 2020, when broader markets made..

Irhythm® Technologies Provides Statement on Medicare Administrative Contractor (Mac) Novitas’s Updated Rate Publication and Provides Commentary on Results for the First Quarter 2021

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recent publication by Novitas Solutions (Novitas) of rates applicable to the Current Procedural Terminology (CPT) codes 93243 and 93247. The company…

IRTC DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against iRhythm Technologies, Inc. – IRTC

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) -- Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) from August 4, 2020 through January 28, 2021, inclusive (the “Class Period”). The lawsuit seeks to recover damag…

IRTC ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against iRhythm Technologies, Inc. – IRTC

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) from August 4, 2020 through January 28, 2021, inclusive (the “Class Period”). The lawsuit seeks to recover damage…

iRhythm Technologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the fourth quarter and full year 2020 after the close of trading on Thursday, February 25, 2021. The compan…

IRTC Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies iRhythm Technologies, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against iRhythm Technologies, Inc. (”iRhythm" or "the Company") (NASDAQ: IRTC) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired iRhyt…
Show more

iRhythm Technologies Blogs

iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer

Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Financial Execution with High Growth Companies SAN FRANCISCO , Sept. 13, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the

iRhythm® Technologies to Present at the 19th Annual Morgan Stanley Global Healthcare Conference

SAN FRANCISCO , Aug. 26, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 19 th Annual Morgan Stanley Global Healthcare

iRhythm Technologies Announces Second Quarter 2021 Financial Results

iRhythm Technologies Announces Second Quarter 2021 Financial Results Content Import Thu, 08/05/2021 - 16:14 iRhythm Technologies Announces Second Quarter 2021 Financial Results August 5, 2021 at 4:05 PM EDT This release is a backfill from a News Wire …

iRhythm® Technologies to Present at the 41st Annual Canaccord Genuity Global Growth Conference

iRhythm® Technologies to Present at the 41st Annual Canaccord Genuity Global Growth Conference Content Import Thu, 07/29/2021 - 16:09 iRhythm® Technologies to Present at the 41st Annual Canaccord Genuity Global Growth Conference July 29, 2021 at 4:05 PM EDT Th…

iRhythm Technologies to Report Second Quarter 2021 Financial Results on August 5, 2021

SAN FRANCISCO , July 22, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the second quarter 2021 after the close of trading on
Show more

iRhythm Technologies Frequently Asked Questions

  • When was iRhythm Technologies founded?

    iRhythm Technologies was founded in 2006.

  • Who are iRhythm Technologies key executives?

    iRhythm Technologies's key executives are Michael J. Coyle, Douglas Devine and Allan Wilsker.

  • How many employees does iRhythm Technologies have?

    iRhythm Technologies has 997 employees.

  • What is iRhythm Technologies revenue?

    Latest iRhythm Technologies annual revenue is $265.2 m.

  • What is iRhythm Technologies revenue per employee?

    Latest iRhythm Technologies revenue per employee is $266 k.

  • Who are iRhythm Technologies competitors?

    Competitors of iRhythm Technologies include Life Plus, SeamlessMD and VitalTech.

  • Where is iRhythm Technologies headquarters?

    iRhythm Technologies headquarters is located at 699 8th St # 600, San Francisco, San Francisco.

  • Where are iRhythm Technologies offices?

    iRhythm Technologies has offices in San Francisco, Cypress, Houston, Lincolnshire and in 1 other location.

  • How many offices does iRhythm Technologies have?

    iRhythm Technologies has 5 offices.